Showing 2,181 - 2,200 results of 100,266 for search '(( i ae decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.75s Refine Results
  1. 2181
  2. 2182
  3. 2183
  4. 2184

    Treatment with <i>T. spiralis</i> AES reduced microscopic colon damage and the myeloperoxidase (MPO) activity induced by DSS in the C57BL/6 mice. by Xiaodi Yang (469303)

    Published 2014
    “…<p>(A) AES treatment decreased the microscopic damage score for the DSS-induced mouse colitis. …”
  5. 2185

    Lithiation of 2,4,5,7-Tetrabromo-1,8-bis(dimethylamino)naphthalene: Peculiarities of Directing Groups’ Effects and the Possibility of Polymetalation by Artyom A. Yakubenko (11602733)

    Published 2021
    “…It was demonstrated that the first exchange occurs in position 4 due to the significant decrease of a steric strain of the molecule. The second exchange takes place in either position 5 or 7 due to the even more negative charge distribution in the naphthalene core. …”
  6. 2186

    <i>In vivo</i> effects of DJ-V-159. by Min Pi (375625)

    Published 2018
    “…<p>(A) The effects of DJ-V-159 on GPRC6A-mediated regulation of insulin secretion in mouse β-cells, MIN-6. …”
  7. 2187
  8. 2188

    Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease by Christine M. LaPash Daniels (796881)

    Published 2015
    “…Here we tested whether lithium treatment would decrease levels of GFAP in a mouse model of Alexander disease. …”
  9. 2189
  10. 2190
  11. 2191
  12. 2192
  13. 2193
  14. 2194
  15. 2195
  16. 2196
  17. 2197
  18. 2198
  19. 2199
  20. 2200

    DataSheet_1_Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.pdf by Haein Kim (4839594)

    Published 2023
    “…Background<p>Immune-evading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are emerging continuously. The clinical effectiveness of monoclonal antibody agents that exhibit decreased in vitro activity against SARS-CoV-2 variants needs to be elucidated.…”